IP Verse

A New Use For Deferiprone - EP1294379B1

PatentPatent Analysis

EP1294379

APOTEX
Application Number
EP01949158A
Filing Date
Jun 28, 2001
Status
Revoked
May 14, 2021
Grant Date
Apr 1, 2009
External Links
Slate, Register, Google Patents

Bibliography

The patent EP1294379B1 was granted to Apotex on Apr 1, 2009 following the initial filing on Jun 28, 2001 under the application number EP01949158A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

LIPOMEDFeb 11, 2020INTERVENTION ADMISSIBLE
LIPOMEDDec 24, 2009ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents